arrow
N

Neerja Bhatla

All India Institute of Medical Sciences
H指数:44
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Global implementation of hereditary cancer care in gynecologic oncology: Development and evaluation of the Hereditary Cancer Care Implementation Index

妇科肿瘤学中遗传性癌症护理的全球实施:遗传性癌症护理实施指数的开发与评估

2026-10-010
PRE
FIGO/IGCS statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions

FIGO/IGCS关于局部治疗预防高危人乳头瘤病毒引起CIN 3+病变有效性的声明

2026-09-300
OAAI
FIGO/IGCS Statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+lesions

FIGO/IGCS 关于局部治疗预防高危人乳头瘤病毒引起CIN 3+病变有效性的声明

2026-09-010
PRE
Clinical Validation of Four Point-of-Care High-Risk HPV Assays, Including Two Reduced-Valency Assays, for Cervical Cancer Screening in Low-Resource Settings

四种即时检测高危HPV检测试剂的临床验证,包括两种低价检测试剂,用于资源匮乏地区的宫颈癌筛查

2026-08-150
OA
Development of a risk prediction model for postpartum onset of type 2 diabetes mellitus, following gestational diabetes; the lifestyle InterVention in gestational diabetes (LIVING) study

妊娠糖尿病产后2型糖尿病发病风险预测模型的建立妊娠糖尿病生活方式干预 (LIVING) 研究

2024-08-011
OAAI
Postpartum glycemic and cardiometabolic profile of women testing positive for gestational diabetes mellitus by International Association of Diabetes and Pregnancy Study Groups (IADPSG) but negative by alternate criteria: Insights from CHIP-F study

国际糖尿病与妊娠研究组协会 (IADPSG) 检测为妊娠糖尿病阳性,但替代标准为阴性的妇女的产后血糖和心脏代谢特征: chip-f研究的见解

2024-06-011
PRE
Antenatal oral glucose tolerance test abnormalities in the prediction of future risk of postpartum diabetes in women with gestational diabetes: Results from the LIVING study

产前口服葡萄糖耐量试验异常可预测妊娠糖尿病妇女产后糖尿病的未来风险: LIVING研究的结果

2024-05-061
OA
Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine
2023-12-112
OAAI